Profile
HSCS ABT BSX-PA BSX SYK MDT
Company Name HeartSciences Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $7.47M $232.75B $175.45B $152.19B $150.29B $120.61B
Employees 0.02K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Andrew Christopher Simpson Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
HSCS ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
HSCS ABT BSX-PA BSX SYK MDT
Last Close $3.005 $133.73 $122.18 $102.71 $383.34 $94.03
High 52 $5.73 $140.22 $122.18 $108.14 $403.53 $94.5
Low 52 $2.59 $111.1 $122.18 $82.52 $337.28 $79.61
Price vs. 52 Week High -47.56 % -4.63 % 0 % -5.02 % -5 % -0.5 %
Price vs. 52 Week Low 16.02 % 20.37 % 0 % 24.47 % 13.66 % 18.11 %
Total Return
HSCS ABT BSX-PA BSX SYK MDT
1 Month Return -14.14 % 3.44 % 0 % -1.38 % 1.29 % 2.23 %
3 Month Return -15.91 % -1.39 % 0 % 2.98 % 1.6 % 7.75 %
6 Month Return 2.39 % 5.54 % 0 % 5.71 % 3.74 % 1.03 %
9 Month Return -20.25 % 17.95 % 0 % 13.98 % 2.33 % 14 %
YTD Return -21.34 % 18.23 % 0 % 14.99 % 6.47 % 17.71 %
1 Year Return -1.15 % 14.89 % 0 % 23.29 % 3.54 % 4.48 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
HSCS ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.73 % - - 0.84 % 2.99 %
Dividend Paid and Capex Coverage Ration (TTM) -245.56 % 1.45 % 4.3 % 4.3 % 2.39 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - - 3.32 % 2.81 %
Payout Ratio (TTM) - 28.42 % 0.92 % 0.92 % 42.87 % 77.26 %
Profitability
HSCS ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 56.78 % 52.79 % 63.23 % 63.23 % 62.19 % 63.44 %
Return on Assets TTM -60207.81 % 16.64 % 6.02 % 6.02 % 6.3 % 5.12 %
Return on Equity TTM -85158.47 % 29.93 % 11.49 % 11.49 % 14.08 % 9.62 %
Return on Capital Employed TTM -457468.2 % 10.7 % 8.53 % 8.53 % 13.86 % 7.71 %
Net Income Per EBT TTM 100 % 176.99 % 83.43 % 83.43 % 87.08 % 82.32 %
EBT Per Ebit TTM 106.94 % 104.64 % 96.68 % 96.68 % 61.93 % 92.49 %
EBIT Per Revenue TTM -54654094.23 % 17.51 % 16.77 % 16.77 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM -248.32 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Receivables Turnover TTM 1 4.21 6.57 6.57 6.08 5.46
Payables Turnover TTM 0.01 4.73 7.07 7.07 6.25 4.89
Inventory Turnover TTM - 2.93 2.38 2.38 1.7 -33.52
Fixed Asset Turnover TTM 1 % 378.32 % 467.97 % 467.97 % 560.03 % -6785.71 %
Asset Turnover TTM 0.1 % 51.32 % 44.5 % 44.5 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -6.66 5.19 2.9 2.9 12.47 5.58
Free Cash Flow Per Share TTM -3779.09 3.89 2.24 2.24 10.53 4.14
Cash Per Share TTM 98.6 % 418.4 % 36.12 % 36.12 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -170413.66 % 20.96 % 23.17 % 23.17 % 20.01 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 56774.11 % 74.97 % 77.27 % 77.27 % 84.43 % 74.21 %
Cash Flow Coverage Ratios TTM -248.32 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Price To Free Cash Flows Ratio TTM - 34.35 46.69 45.97 37.35 22.74
Price To Operating Cash Flows Ratio TTM -0.5 25.76 36 35.44 31.52 16.86
Price Cash Flow Ratio TTM -0.5 25.76 36 35.44 31.52 16.86
Income Statement (TTM)
HSCS ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio 56.78% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $-0.01B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -9.34 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
HSCS ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
HSCS ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $-0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 133.73
ADGM Adagio Medical Holdings, Inc. 1.72
AEMD Aethlon Medical, Inc. 0.7732
AFIB Acutus Medical, Inc. 0.002
AHCO AdaptHealth Corp. 9.29
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 131.56
ALUR Allurion Technologies Inc. 2.16
AMIX Autonomix Medical, Inc. Common Stock 1.11
ANIK Anika Therapeutics, Inc. 8.67
AORT Artivion, Inc. 40.7
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.1
ARAY Accuray Incorporated 1.57
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.26
AVNS Avanos Medical, Inc. 12.22
AVR Anteris Technologies Global Corp. Common Stock 5.57
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to HSCS
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00001 208.84
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00001 158.47
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00001 158.48
VEMPX Vanguard Extended Market Index InstlPlus 0.00001 391.07
Unlock